000 01793cam  2200313za 4500
0019.850234
003CaOODSP
00520221107154118
007cr |||||||||||
008180117s2017    onca   #ob   f000 0 eng d
020 |a978-0-660-24572-0
040 |aCaOODSP|beng
043 |an-cn---
0861 |aHP40-206/2018E-PDF
24500|aReport on the enhanced surveillance of antimicrobial-resistant gonorrhea |h[electronic resource] : |bresults from the 2014 pilot.
260 |aOttawa : |bPublic Health Agency of Canada, Infectious Disease Prevention and Control Branch, |c2017.
300 |ai, 32 p. : |bill.
500 |a"September 2017."
500 |aTitle from cover.
500 |a"Protecting and empowering Canadians to improve their health"--Cover.
500 |aIssued also in French under title: Rapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens : résultats de la phase pilote de 2014.
504 |aIncludes bibliographical references.
520 |a"Gonorrhea is the second most common bacterial sexually transmitted infection (STI) in Canada with over 16,000 cases annually. Antimicrobial resistance (AMR) in Neisseria gonorrhoeae (N. gonorrhoeae) is a serious threat to effective treatment of gonococcal infections"--Executive summary, p. 2.
69207|2gccst|aSexually transmitted diseases
69207|2gccst|aInfectious diseases
69207|2gccst|aMedical research
7102 |aPublic Health Agency of Canada. |bInfectious Disease Prevention and Control Branch.
77508|tRapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens |w(CaOODSP)9.850235
85640|qPDF|s731 KB|uhttps://publications.gc.ca/collections/collection_2018/aspc-phac/HP40-206-2018-eng.pdf